Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   
National Institute on Drug Abuse News Release NIDA Information
RELEASED, January 13, 1999

NIDA Launches a Major Effort to Establish National Drug Abuse Treatment Clinical Trials Network


The National Institute on Drug Abuse (NIDA), National Institutes of Health, is taking a major step forward in establishing a critically needed research infrastructure that will test and disseminate science-based addiction treatments in real life settings throughout the country. NIDA is pleased to announce the establishment of its National Drug Abuse Treatment Clinical Trials Network (CTN).

As has been established for other diseases, such as cancer and AIDS, this Network will allow NIDA to establish a research infrastructure that is able to efficiently and effectively test a variety of pharmacological and behavioral treatment modalities in real life settings and diverse patient populations.

The Network will literally allow us the opportunity to move efficacious research right into practice. Once established, we think it will make a significant impact on how treatment is provided in this country.

NIDA will make four awards in 1999, and invites grant applications from established clinical investigators wishing to participate. The CTN is advertised as RFA #DA-99-004. For a copy of the RFA, please call NIDA's Office of Extramural Program Review at 301-443-2755, or print a copy from the Web at http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-99-004.html. Critical deadlines are March 13 for a letter of intent and April 13 for the application receipt date.

The need for this Network has been identified by the drug abuse treatment field, and also was recommended by the 1998 Institute of Medicine Report, Bridging the Gap Between Research and Practice, as the single mechanism most likely to improve drug abuse treatment in this country. The CTN will enable rapid, concurrent testing of a wide range of promising science-based behavioral therapies, medications, and their combined use across a range of patient populations, treatment settings, and community environments nationwide.

When complete, the network will consist of 20 to 30 sites in regions throughout the country. These nodes will consist of Regional Research and Training Coordinating Centers (RRTCs), based in university medical and research centers. Each RRTC will be linked with 10 to 15 community treatment providers that represent a variety of treatment settings and patient populations available in the region. For further information on programmatic issues of the CTN, please call Dr. Jack Blaine at 301-443-0107 or Dr. Betty Tai at 301-443-2397.

NIDA supports more than 85 percent of the world's research on the health aspects of drug abuse and addiction. The Institute also carries out a large variety of programs to ensure the rapid dissemination of research information and its implementation in policy and practice. Fact sheets on health effects of drugs of abuse and other topics can be ordered free of charge in English and Spanish, by calling NIDA Infofax at 1-888-NIH-NIDA (-644-6432) or 1-888-TTY-NIDA (-889-6432) for the deaf. These fact sheets and further information on NIDA research and other activities can be found on the Home page at http://www.nida.nih.gov/.


The National Institute on Drug Abuse
is a component of the National Institutes of Health,
U.S. Department of Health and Human Services

News Release Index



Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal